Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TG6050 |
Trade Name | |
Synonyms | TG-6050|TG 6050 |
Drug Descriptions |
TG6050 is an oncolytic vaccinia virus engineered to express IL-12 and an anti-CTLA4 antibody, which potentially leads to enhanced antitumor immune response and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 694). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TG6050 | TG6050 | 0 | 1 |